Envision

Treat the Cause of Dry Eyes, not Just the Symptoms

Find A Provider Contact Us

InMode's non-surgical alternative to treat the cause of dry eye.

Envision offers a non-drug therapy to improve your patient's vision and quality of life!

Envision is the new in-office standard revolutionising ocular care procedures for the treatment of meibomian gland dysfunction (MGD) and the symptoms of dry eye disease (DED).

This ground breaking, non-surgical ophthalmic device, deploys multiple programmable modalities which work synergistically to deliver precision ocular treatments.

Envision’s small-size, bipolar radiofrequency (RF) and Intense Pulsed Light (IPL) applicators with precise depth control allowing for highly efficacious procedures in the small, more delicate subdermal layers of the periorbital region.

The Morpheus8 Prime fractional radio-frequency microneedling technology allows for droopy eyelids to be tightened.

Forma-I (bipolar radiofrequency) addresses the symptoms of dry eye disease (DED) caused by Meibomian Gland Dysfunction (MGD). Intended for use in the the periorbital area and upper and lower lids and relieves inflammation of meibomian glands and eye irritation.

Lumecca-I is an effective treatment of benign pigmented epidermal lesions and benign cutaneous vascular lesions.Lumecca was developed with an advanced xenon flash lamp producing 40% of total pulse energy in the 500-600 nm range. IPL energy penetrates the skin and is selectively absorbed by lesion chromophores (melanin or hemoglobin).

Morpheus8 is a minimally invasive fractional technology for dermatological and general surgical procedures for electrocoagulation and hemostasis. It is a clinically proven fractional technology
designed to treat tissue. RF energy is delivered to multiple treatment depths through bipolar arrays of microneedles and results in localised heating and coagulation of tissue.

Before/After

Before

After

Drag

Before/After

Before

After

Drag

Before/After

Before

After

Drag
Ophthalmologist Dr Bruce Dornn on Envision by InMode

Clinical Papers

Download our clinical papers for Define below.

Clinical Study

Transcutaneous Radiofrequency-mediated Meibomian Gland Expression is an Effective Treatment for Dry Eye: A Prospective Cohort Trial

PATIENT

Ready for a Envision Treatment?

CLINIC

Looking to expand your clinic offerings?

Frequently Asked Questions

CONTACT US

Have any queries?

Want to know more about Envision? Contact us.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.